BridgeBio Pharma, Inc. Purchase Agreements

5 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement between BridgeBio Pharma, Inc. and Purchasers (September 25, 2023)
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
CA
2023
BridgeBio Pharma, Inc. $650,000,000 2.25% Convertible Senior Notes Due 2029 Purchase Agreement with Initial Purchasers
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2021
BridgeBio Pharma, Inc. $475,000,000 2.500% Convertible Senior Notes Due 2027 Purchase Agreement with Initial Purchasers
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2020
Asset Purchase Agreement among Phoenix Tissue Repair, Inc., Shire Human Genetic Therapies, Inc., and Lotus Tissue Repair, Inc. dated July 21, 2017
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
NY
2019
Asset Purchase Agreement between Alexion Pharma Holding Unlimited Company, Origin Biosciences, Inc., and BridgeBio Pharma, LLC (June 7, 2018)
Purchase Agreements
BridgeBio Pharma, Inc.
Biotechnology
DE
2019